Orthobiologics Market Report 2021: Size, Share Trends, Industry Growth & Future Scope 2026
According to the latest report by IMARC Group, titled, “Orthobiologics Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global orthobiologics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.
Orthobiologics are prescription drugs made by living organisms to heal orthopedic tissues. Some of the common orthobiologics include bone marrow concentrate, platelet-rich plasma (PRP), birth tissues and certain fat grafts. These are autologous or allogeneic substances that are injected or placed surgically toacceleratethe healing of bones, joints, muscles, or tendons.Nowadays, platelet-rich plasma (PRP) is a rapidly gaining tractionin the field of regenerative medicine, showing excellent potential in triggering or expediting the healing process in bones, muscles and ligaments.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Orthobiologics Market Trends:
The market is primarily driven by the increasing prevalence of osteoarthritis(OA), especially among the geriatric population. Older adultsare also highly susceptible to spinal and other orthopedic disorders, resulting in the need foran increased number of orthopedic procedures. Besides this, the rising awareness among physicians and patients aboutthe benefits oforthobiologic therapies and newly introduced treatment procedures and technologies have encouraged them to opt for orthobiologics. Moreover, extensive investments and collaborations by prominent medical device and biotechnology companies in the research and development (R&D) to produce advanced orthobiologics are providing a positive market outlook. Some of the other factors, including the growing preference for minimally invasive (MI) procedures, improving healthcare infrastructure and advent of next-generation biologics technology, are also contributing to the market growth.
Request a Free Sample Report: https://www.imarcgroup.com/orthobiologics-market/requestsample
Orthobiologics Market 2021-2026 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Arthrex Inc, Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries Inc., Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Wright Medical Group N.V. and Zimmer Biomet.
The report has segmented the market on the basis on product, type, application and end user.
Breakup by Product:
- Demineralized Bone Matrix
- Bone Morphogenetic Protein
- Viscosupplementation Products
- Synthetic Bone Substitutes
Breakup by Type:
- Wrist and Shoulder
Breakup by Application:
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Fracture Recovery
- Soft Tissue Injuries
- Maxillofacial and Dental Applications
Breakup by End User:
- Hospitals and Ambulatory Centers
- Research and Academic Institutes
- Dental Clinics and Facilities
- Orthopedic Clinics
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/orthobiologics-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Browse Other Reports by IMARC Group:
GCC Telemedicine Market Report 2021-2026 – https://www.imarcgroup.com/gcc-telemedicine-market
COVID-19 Diagnostics Market Report 2021-2026- https://www.imarcgroup.com/covid-19-diagnostics-market
Disposable Masks and Respirators Market Report 2020-2025: https://www.imarcgroup.com/disposable-masks-respirators-market
Cone Beam Imaging Market Report 2021-2026: https://www.imarcgroup.com/cone-beam-imaging-market
Glaucoma Therapeutics Market Report 2020-2025: https://www.imarcgroup.com/glaucoma-therapeutics-market
Anesthesia Endotracheal Tubes Market 2020-2025: https://www.imarcgroup.com/anesthesia-endotracheal-tubes-market
Cannula Market Report 2021-2026: https://www.imarcgroup.com/cannula-market
Europe Dental Implants Market Report 2020-2025: https://www.imarcgroup.com/europe-dental-implants-market
United States Dental Implants Market Report 2020-2025: https://www.imarcgroup.com/united-states-dental-implants-market
Blood Bags Market Report 2021-2026: https://www.imarcgroup.com/blood-bags-market
Fractional Flow Reserve Market Report 2021-2026: https://www.imarcgroup.com/fractional-flow-reserve-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800